RFK Jr.'s 'Make America Healthy Again' agenda focuses on overhauling health care and food to combat chronic disease ...

On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at ...

Today's health news includes understanding Plan B's efficacy for people with higher BMIs, disparities in infant mortality, ...

In choosing Thune, Republicans went with an establishment candidate with close ties to the outgoing and long-time Senate ...

Reversing an earlier decision, European regulators recommended that an Alzheimer’s therapy from Eisai and Biogen should be ...

For a fifth time this year, the FDA has scolded a pharma company for misleading marketing, this time over a Merz ...

Measles vaccination coverage globally has still not recovered to pre-Covid levels, a fact that contributed to a 20% increase ...

Facing with a dialogue with RFK Jr., a top FDA official mounts a public defense of vaccines — and pleads for open minds.

Good morning health tech readers! Today, details about Amazon’s new mental health partner, another digital health company ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

A critical way to help our impaired health care system is therefore to encourage and use chaplains more. Hospital ...